Premium
APPLICATION OF CELL ENGINEERING TECHNOLOGY TO THE TUMOUR IMMUNOTHERAPEUTIC DRUG: A REVIEW
Author(s) -
Chen Z. N.,
Xing J. L.,
Bian H. J.,
Mi L.,
Jiang J. L.
Publication year - 2001
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1006/cbir.2001.0753
Subject(s) - immunotherapy , monoclonal antibody , drug , computational biology , medicine , computer science , immunology , antibody , biology , immune system , pharmacology
The concept of cell engineering is frequently mentioned in recent years. It's a comprehensive technology which is very powerful and useful. By using it, scientists can produce many kinds of proteins and other biological moleculars in large scale that are in great demand for the human being. Among these products, most can be used for tumor immunotherapy and have been confirmed to be very effective in tumour control or subsidiary treatment. Of them, most common and useful drugs include three sorts; tumour vaccines, cell factors and monoclonal antibodies. The paper will discuss in detail related drugs application advances in tumour immunotherapy.